Using chronic MOG35–55-induced experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, we investigated here the curative potential of peripheral orexin A administration in the clinical development of ongoing disease. Here, HCRT is linked to myeloid sarcoma.